Novel roles of the tumor microenvironment have introduced in regulating drug resistance, and macrophages in microenvironment have been proposed as factors contributing to the resistances of PI3K inhibitors through the activation of NF-κB signaling [211]. The gene discussed is PIK3CD; the disease is neoplasm.